BioCentury
ARTICLE | Company News

Bolder BioTechnology other research news

January 17, 2005 8:00 AM UTC

Bolder announced that National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $500,000 Phase I SBIR grant to optimize the manufacturing process and perform preclinical toxic...